Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)

SHE:002287 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	13,883	11,346	11,924	12,061	16,133	13,690
Market Cap Growth	19.08%	-4.85%	-1.14%	-25.24%	17.84%	18.61%
Enterprise Value	11,897	9,899	11,823	11,874	15,564	12,825
Last Close Price	24.38	20.65	21.17	21.15	27.61	23.13
PE Ratio	21.26	19.49	20.52	25.52	22.54	33.89
Forward PE	-	43.51	43.51	43.51	43.51	43.51
PS Ratio	5.81	4.85	5.83	5.90	9.11	9.22
PB Ratio	2.86	2.76	3.16	3.56	5.01	5.20
P/TBV Ratio	3.09	3.04	3.54	4.07	5.83	5.60
P/FCF Ratio	24.41	56.36	26.00	907.60	17.74	-
P/OCF Ratio	19.07	24.84	17.20	42.22	15.59	57.60
EV/Sales Ratio	4.98	4.23	5.78	5.81	8.79	8.64
EV/EBITDA Ratio	19.30	15.35	21.38	19.66	32.65	32.36
EV/EBIT Ratio	24.76	18.44	25.29	22.50	37.37	36.38
EV/FCF Ratio	20.92	49.17	25.78	893.55	17.11	-
Debt / Equity Ratio	0.20	0.41	0.41	0.50	0.45	0.46
Debt / EBITDA Ratio	1.60	2.59	2.74	2.78	3.01	3.05
Debt / FCF Ratio	1.74	8.44	3.35	127.68	1.60	-
Asset Turnover	0.36	0.36	0.34	0.36	0.35	0.40
Inventory Turnover	1.82	2.46	2.29	2.64	2.53	2.77
Quick Ratio	2.39	2.37	2.40	2.23	2.12	3.75
Current Ratio	2.63	2.50	2.57	2.35	2.25	3.89
Return on Equity (ROE)	13.94%	14.75%	16.18%	14.21%	24.28%	16.51%
Return on Assets (ROA)	4.56%	5.13%	4.79%	5.76%	5.19%	5.92%
Return on Invested Capital (ROIC)	16.34%	16.78%	14.44%	17.06%	15.90%	20.04%
Return on Capital Employed (ROCE)	9.40%	10.50%	9.30%	11.70%	9.80%	9.50%
Earnings Yield	4.41%	5.13%	4.87%	3.92%	4.44%	2.95%
FCF Yield	4.10%	1.77%	3.85%	0.11%	5.64%	-0.74%
Dividend Yield	1.81%	1.84%	2.27%	1.84%	2.14%	1.47%
Payout Ratio	74.06%	48.51%	37.86%	72.06%	27.31%	47.82%
Buyback Yield / Dilution	-0.77%	-0.03%	0.05%	-0.21%	-0.12%	-0.03%
Total Shareholder Return	1.04%	1.81%	2.31%	1.63%	2.02%	1.44%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.